Novartis presents significant study results during renowned Best of ESMO Conference in Dubai

• Participating healthcare professionals attended the exclusively organized event by the Emirates Oncology Society in collaboration with the European Society of Medical Oncology targeting the Middle East and Africa region to bring the content and copyright of the data presented during the ESMO conference in September.
•  As the diamond sponsor of the event, Novartis also presented prominent study results for Phase III MONALEESA-2 as part of their latest medical updates and industry developments.